Ask AI

Navigating Complex Refractory CMV Cases in SOT Recipients: Expert Approaches

With these activities, learn to employ best practices for timely identification of refractory cytomegalovirus (CMV) infections following solid organ transplantation (SOT) and design or modify antiviral regimens for refractory CMV infections to minimize toxicities and maximize efficacy.

Share

Program Content

Activities

Refractory CMV in SOT
Strategies for Optimizing Antiviral Treatment of Refractory CMV Infections in Solid Organ Transplant Recipients
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options (CCO) in partnership with ProCE

Supporters

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Takeda Pharmaceuticals U.S.A., Inc.

Partners

ProCE, LLC

ProCE Banner